INS and diabetes mellitus: Insulin restrictors had significantly higher HbA1c (9.2 ± 2.2; p < 0.001), later onset of diabetes (11.6 ± 4.5; p = 0.041), and significantly higher DEPS-R scores (24.8 ± 10.4; p < 0.001) (Table 3).